An enhanced sampling method is developed for molecular dynamics based on trained machine learning force fields to guide the construction of PANoptosis‐inhibiting carbonized polymer dots (Lu‐CDs) derived from a flavonoid compound for treating chemodrug‐induced nephrotoxicity.
Xinchen Liu +8 more
wiley +1 more source
Efficacy of EGb 761<sup>®</sup> and Betahistine in Treatment of Dizziness/Vertigo: A Randomized Double-Blind Controlled Trial. [PDF]
Jianbunjongkit N +2 more
europepmc +1 more source
Corrigendum to “A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods” [Contemporary Clinical Trials 122 (2022) 1-11/106909] [PDF]
Marie‐Louis Wronski +15 more
openalex +1 more source
Guilty at First Sight: Legislation to Prevent the Misidentification of Innocent Persons in Illinois [PDF]
Murphy, Kaitlyn A.
core +1 more source
Tumor evolution in lung adenocarcinoma is shaped by genetic alterations and spatial immune dynamics. By integrating whole‐exome sequencing, imaging mass cytometry, and spatial transcriptomics across two mouse models, this study reveals how mutational burden, immune infiltration, and cell–state interactions evolve during early and late carcinogenesis ...
Bo Zhu +34 more
wiley +1 more source
Midazolam oral solution for neonatal MRI: study protocol of a randomised controlled trial. [PDF]
Cheng Z +5 more
europepmc +1 more source
In hepatocellular carcinoma (HCC), aberrantly activated Notch1 signaling induces its target gene YY1, which impairs immunotherapy efficacy by suppressing tumor cell‐ICAM1‐driven T cell activation and the mediated pyroptosis of T cells against tumor cells.
Ke Zhu +10 more
wiley +1 more source
Double versus single fluoroscopy for screw fixation of slipped capital femoral epiphysis: does double fluoroscopy improve outcomes? A retrospective comparative study. [PDF]
Bacaksız T +6 more
europepmc +1 more source
By integrating a convergent molecular platform strategy, this study designed a novel dual‐target C5 to combat multidrug‐resistant Gram‐negative bacteria. C5 synergistically enhances antibiotic efficacy by inhibiting efflux pumps and increasing bacterial membrane permeability.
Jiale Dong +11 more
wiley +1 more source

